Agios Pharmaceuticals, Inc. (AGIO) vs Palvella Therapeutics, Inc. (PVLA)
- Agios Pharmaceuticals, Inc. AGIO 31.32 −3.09%
- Palvella Therapeutics, Inc. PVLA 120.30 −5.53%
Agios Pharmaceuticals, Inc. and Palvella Therapeutics, Inc. are both Biotechnology companies. Agios Pharmaceuticals, Inc. and Palvella Therapeutics, Inc. are of similar size ($1.9B and $1.8B). Palvella Therapeutics, Inc. grew revenue faster over the last twelve months: 146.7% against 140.6%. Palvella Therapeutics, Inc. has the higher net margin (0.00% vs −418.2%) and the higher return on invested capital (0.00% vs −70.2%). Across the 17 metrics below, Palvella Therapeutics, Inc. leads on 12 and Agios Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | AGIO | PVLA | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.99% | 100.00% | 65.16% |
| Operating margin | (466.78%) | 0.00% | 0.00% |
| Net margin | (418.24%) | 0.00% | 0.00% |
| Free cash flow margin | (371.43%) | 0.00% | 0.00% |
| Return on equity | (34.34%) | (46.63%) | (56.36%) |
| Return on assets | (31.89%) | (37.70%) | (48.04%) |
| Return on invested capital | (70.24%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack